Skip to main content
NIH funding notice RFA-AT-24-001

Research Network to Promote Multidisciplinary Mechanistic and Translational Studies of Sickle Cell Disease Pain (U24, Clinical Trial Optional)

Closed on October 1, 2023.

Posted
February 27, 2023
Close date
October 1, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$963,947
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA-IRVINE1

Most frequent study sections

  1. Special Emphasis Panel (ZAT1 MH (08))1
1 award under RFA-AT-24-001 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2024Sickle Cell Disease Pain Analgesia And Integrative Network1U24AT012868-01Campbell, Claudia MichelleGupta, KalpnaSmith, Wally RUNIVERSITY OF CALIFORNIA-IRVINE, CAFirst-year cost $963,947Study section ZAT1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.